OH Consultant

Pharmaceutical: EHS Management That Works When You're Not Looking

Pharmaceutical manufacturing operates at the intersection of GMP quality requirements and WHS compliance obligations. Active pharmaceutical ingredients require OEB-banded containment, formaldehyde drops 70% to 0.3 ppm, and the chemical register must track substances that range from benign excipients to potent compounds requiring nanogram-level containment. Both the quality auditor and the WHS inspector expect documentation — and they look for different things.

-70%
Formaldehyde WEL reduction
Safe Work Australia WEL List
10-30+
OEB-banded APIs in typical facility
Industry benchmark
10
Codes of Practice becoming binding
SafeWork NSW — Section 26A

What keeps pharmaceutical managers up at night

OEB banding and containment validation

API manufacturing requires occupational exposure banding (OEB) to determine containment requirements. Each compound has a different potency and a different required control level. The chemical register must reflect OEB assignments, containment validation status, and engineering control adequacy for every API in production. WEL changes may alter the assessment for compounds where the incoming WEL is more restrictive than the current OEB assignment.

WHS Regulation 2025, Chapter 7; Code of Practice — Managing risks of hazardous chemicals

Cross-contamination as both quality and safety hazard

Pharmaceutical manufacturing treats cross-contamination as a GMP issue, but it is equally a WHS issue when potent compounds can affect worker health through dermal or inhalation exposure. Cleaning validation, changeover procedures, and facility design must satisfy both quality and safety requirements.

WHS Act 2011, s.19 (primary duty)

Formaldehyde in laboratory and process environments

Formaldehyde is used in pharmaceutical QC laboratories and some manufacturing processes. The WEL drops from 1 ppm to 0.3 ppm — a 70% reduction. Laboratories using formaldehyde-based fixatives, histology reagents, or disinfectants must reassess ventilation adequacy against the new limit.

Safe Work Australia WEL List

What's changing for pharmaceutical manufacturing in 2026

WEL Impact (3 substances affected)

SubstanceCurrent WESNew WELChangeEffective
Formaldehyde1 ppm0.3 ppm-70%1 December 2026
Active pharmaceutical ingredients (OEB-banded)OEB-dependentOEB-dependent (review required)VariableOngoing
Isopropyl alcohol (IPA)400 ppm200 ppm-50%1 December 2026

Section 26A Applicable Codes (10)

Managing risks of hazardous chemicals
Governs the chemical register, SDS management, OEB-banded API tracking, and control measures for all hazardous substances in the facility
Confined spaces
Applies to entry into reactors, vessels, and process equipment during maintenance and cleaning
Managing noise and preventing hearing loss
Production equipment, HVAC systems, and process machinery may generate noise levels requiring assessment
How to manage work health and safety risks
The overarching risk management code applicable to all pharmaceutical operations
Labelling of workplace hazardous chemicals
Ensures correct labelling of all chemicals including APIs, intermediates, and process chemicals

Penalty Exposure

Max Individual
$2,318,844 (Category 1) or $447,122 (Category 2)
Max Body Corporate
$11,150,183 (Category 1) or $2,235,363 (Category 2)
Uninsurable Since
10 June 2020
Recent Prosecution
Chemical and pharmaceutical sector prosecutions focus on containment failures and health monitoring gaps, with fines routinely exceeding $300,000 for Category 2 offences.

How EHS Atlas solves this for pharmaceutical manufacturing

FlaskConical
API tracking with OEB banding and WEL mapping
Every substance tracked with OEB assignment, containment validation status, and WEL mapping. APIs, intermediates, excipients, and process chemicals in a single register. Automatic flagging when incoming WEL is more restrictive than current OEB assignment.
New API enters production. System registers OEB band, maps to containment requirements, and checks incoming WEL. Flags if current engineering controls may be insufficient.
ShieldAlert
Containment validation linked to regulatory requirements
Structured risk assessments for API handling, laboratory operations, and process activities. Each assessment references applicable WHS Regulation sections, Codes of Practice, and GMP requirements.
Containment validation risk assessment for a potent API maps OEB band to required engineering controls and references the Managing Risks of Hazardous Chemicals Code.
GraduationCap
GMP-aligned WHS training — potent compounds, spill response
Track training for potent compound handling, spill response, RPE fitting, and chemical-specific procedures. GMP-aligned training records satisfy both quality and safety auditors.
Operator assigned to new potent API line. System flags: compound-specific handling training, RPE fit test, and health monitoring baseline required before entering production area.
ClipboardCheck
Cleanroom containment, fume hood airflow, eye wash stations
Scheduled inspections for containment equipment, fume hood face velocities, eye wash stations, and emergency equipment. Results logged with photo evidence.
Quarterly fume hood face velocity test shows below-minimum airflow in QC lab. Corrective action assigned. Hood restricted until airflow restored.
AlertTriangle
Exposure incidents with potent compound protocols
Structured incident logging for chemical exposure events. Potent compound incidents trigger specific response protocols including medical assessment and containment verification.
Operator reports skin contact with potent API during transfer. Incident logged. System activates potent compound exposure protocol: immediate medical assessment, containment review, root cause investigation.
BarChart3
Formaldehyde and API-specific limits tracked
All substances mapped against incoming WEL. Formaldehyde flagged for 70% reduction. OEB-banded APIs cross-referenced with WEL changes. Days-until-deadline counter.
Dashboard shows formaldehyde as red (-70%). Three APIs flagged amber where incoming WEL may be more restrictive than current OEB assignment. Action plan generated.
Scale
10 codes including chemical management
Track compliance status for each of the 10 applicable Codes of Practice. Generate evidence of compliance that satisfies both WHS inspector and quality auditor requirements.
Managing Risks of Hazardous Chemicals Code mapped to your API handling procedures. Tracker confirms GMP-aligned procedures meet code requirements or flags gaps.

Your pharmaceutical compliance calendar

January
Annual OEB review — all APIs in production
WHS Regulation 2025, Chapter 7
OEB assignments must reflect current toxicological data
March
Fume hood and containment equipment verification
Code of Practice — Managing risks of hazardous chemicals
Containment failure = potent compound exposure risk
May
Health monitoring review — formaldehyde and potent compound exposed workers
WHS Regulation 2025, Chapter 7 Part 7.1 Div 6
Failure to provide health monitoring is a specific offence
June
Pre-July s.26A readiness — verify 10 codes documented
WHS Act s.26A
Non-compliance from 1 July 2026 is a breach
July
Section 26A takes effect — codes legally binding
WHS Act 2011 s.26A
Must follow code or document alternative
September
Chemical register audit — new APIs, discontinued products, SDS currency
WHS Regulation 2025, s.346
Unregistered chemicals = improvement notice
November
Final WEL readiness — formaldehyde, IPA, and any affected APIs
Safe Work Australia WEL List
30 days to transition
December
WEL takes effect — all monitoring against new limits
WHS Regulation 2025 (as amended)
Immediate enforcement

See EHS Atlas configured for pharmaceutical manufacturing

OEB-banded chemical register, GMP-aligned templates, and formaldehyde tracking — 15-minute walkthrough.